{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:28:08Z","timestamp":1768782488721,"version":"3.49.0"},"reference-count":106,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2012]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Chronic heart failure (HF) with either reduced or preserved left ventricular (LV) ejection fraction is common and remains an extremely serious disorder with a high mortality and morbidity. Many complications related to heart failure can be related to thrombosis. Epidemiological and pathophysiological data also link HF to an increased risk of thrombosis, leading to the clinical consequences of sudden death, stroke, systemic thromboembolism and\/or venous thromboembolism. This executive summary of a joint consensus document of the Heart Failure Association (EHFA) of the European Society of Cardiology (ESC) and the ESC Working Group on Thrombosis reviews the published evidence, summarises \u2018best practice\u2019, and puts forward consensus statements that may help to define evidence gaps and assist management decisions in everyday clinical practice. In HF patients with atrial fibrillation, oral anticoagulation is clearly recommended, and the CHA2DS2-VASc and HAS-BLED scores should be used to determine the likely risk-benefit ratio (thromboembolism prevention versus risk of bleeding) of oralnticoagulation. In HF patients with reduced LV ejection fraction who are in sinus rhythm there is no evidence of an overall benefit of vitamin K antagonists (e.g. warfarin) on mortality, with risk of major bleeding. Whilst there is the potential for a reduction in ischaemic stroke, there is currently no compelling reason to routinely use warfarin for these patients. Risk factors associated with increased risk of thromboembolic events should be identified and decisions regarding use of anticoagulation individualised. Patient values and preferences are important determinants when balancing the risk of thromboembolism against bleeding risk. Novel oral anticoagulants that offer a different risk-benefit profile compared with warfarin may appear as an attractive therapeutic option, but this would need to be confirmed in clinical trials.<\/jats:p><jats:p>Note: The editorial process for this article was fully handled by Prof. Christian Weber, Editor in Chief.<\/jats:p>","DOI":"10.1160\/th12-08-0578","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T15:24:39Z","timestamp":1351005879000},"page":"1009-1022","source":"Crossref","is-referenced-by-count":52,"title":["Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm"],"prefix":"10.1160","volume":"108","author":[{"given":"Piotr","family":"Ponikowski","sequence":"first","affiliation":[]},{"given":"Felicita","family":"Andreotti","sequence":"first","affiliation":[]},{"given":"Stefan","family":"Anker","sequence":"first","affiliation":[]},{"given":"Gerasimos","family":"Filippatos","sequence":"first","affiliation":[]},{"given":"Shunichi","family":"Homma","sequence":"first","affiliation":[]},{"given":"Joao","family":"Morais","sequence":"first","affiliation":[]},{"given":"Patrick","family":"Pullicino","sequence":"first","affiliation":[]},{"given":"Lars","family":"Rasmussen","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Marin","sequence":"first","affiliation":[]},{"given":"Deirdre","family":"Lane","sequence":"first","affiliation":[]},{"given":"J.","family":"McMurray","sequence":"first","affiliation":[]},{"given":"A.","family":"Hoes","sequence":"first","affiliation":[]},{"given":"J.","family":"Ten Berg","sequence":"first","affiliation":[]},{"given":"R.","family":"De Caterina","sequence":"first","affiliation":[]},{"given":"S. D.","family":"Kristensen","sequence":"first","affiliation":[]},{"given":"U.","family":"Zeymer","sequence":"first","affiliation":[]},{"given":"Gregory","family":"Lip","sequence":"additional","affiliation":[]}],"member":"194","published-online":{"date-parts":[[2017,11,29]]},"reference":[{"key":"10.1160\/TH12-08-0578-1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2007.01.009"},{"key":"10.1160\/TH12-08-0578-2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9520-y"},{"key":"10.1160\/TH12-08-0578-3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.10.018"},{"key":"10.1160\/TH12-08-0578-4","doi-asserted-by":"crossref","unstructured":"Lip GY, et al. Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open 2012; 2: pii: e000975.","DOI":"10.1136\/bmjopen-2012-000975"},{"key":"10.1160\/TH12-08-0578-5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.6.611"},{"key":"10.1160\/TH12-08-0578-6","doi-asserted-by":"crossref","unstructured":"Healey JS, et al.; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-129","DOI":"10.1056\/NEJMoa1105575"},{"key":"10.1160\/TH12-08-0578-7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.10.014"},{"key":"10.1160\/TH12-08-0578-8","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-03-0168"},{"key":"10.1160\/TH12-08-0578-9","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs073"},{"key":"10.1160\/TH12-08-0578-10","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-04-0247"},{"key":"10.1160\/TH12-08-0578-11","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00033-9"},{"key":"10.1160\/TH12-08-0578-12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi001"},{"key":"10.1160\/TH12-08-0578-13","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90670-X"},{"key":"10.1160\/TH12-08-0578-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.09.113"},{"key":"10.1160\/TH12-08-0578-15","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143073.60937.50"},{"key":"10.1160\/TH12-08-0578-16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1160\/TH04-05-0278","volume":"92","author":"Alehagen","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1160\/TH12-08-0578-17","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-03-0169"},{"key":"10.1160\/TH12-08-0578-18","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-06-0399"},{"key":"10.1160\/TH12-08-0578-19","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000047852.05842.3C"},{"key":"10.1160\/TH12-08-0578-20","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000227121.34717.40"},{"key":"10.1160\/TH12-08-0578-21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.07.011"},{"key":"10.1160\/TH12-08-0578-22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.208"},{"key":"10.1160\/TH12-08-0578-23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.4.626"},{"key":"10.1160\/TH12-08-0578-24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03340210040022"},{"key":"10.1160\/TH12-08-0578-25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.03.064"},{"key":"10.1160\/TH12-08-0578-26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2077"},{"key":"10.1160\/TH12-08-0578-27","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90757-M"},{"key":"10.1160\/TH12-08-0578-28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90523-K"},{"key":"10.1160\/TH12-08-0578-29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(81)90534-8"},{"key":"10.1160\/TH12-08-0578-30","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(83)90588-X"},{"key":"10.1160\/TH12-08-0578-31","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.62.1.26"},{"key":"10.1160\/TH12-08-0578-32","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.2.314"},{"key":"10.1160\/TH12-08-0578-33","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.58.4.393"},{"key":"10.1160\/TH12-08-0578-34","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90286-4"},{"key":"10.1160\/TH12-08-0578-35","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(07)80021-4"},{"key":"10.1160\/TH12-08-0578-36","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015073"},{"key":"10.1160\/TH12-08-0578-37","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2011.11.012"},{"key":"10.1160\/TH12-08-0578-38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"issue":"6 Suppl","key":"10.1160\/TH12-08-0578-39","first-page":"VI94","volume":"87","author":"Dunkman","year":"1993","journal-title":"Circulation"},{"key":"10.1160\/TH12-08-0578-40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.661397"},{"key":"10.1160\/TH12-08-0578-41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701233360403"},{"key":"10.1160\/TH12-08-0578-42","doi-asserted-by":"crossref","unstructured":"Dries DL, et al. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29: 1074-1080. Erratum in J Am Coll Cardiol 1998; 32: 555","DOI":"10.1016\/S0735-1097(97)00019-3"},{"key":"10.1160\/TH12-08-0578-43","unstructured":"Falk RH, et al. The effect of warfarin on prevalence of stroke in patients with severe heart failure. J Am Coll Cardiol 1993; 21: 218 (Abstract)"},{"key":"10.1160\/TH12-08-0578-44","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00006-0"},{"key":"10.1160\/TH12-08-0578-45","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00502-0"},{"key":"10.1160\/TH12-08-0578-46","doi-asserted-by":"crossref","unstructured":"Sampson UK, et al.; VALIANT Trial Investigators. Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial. Eur Heart J 2007; 28: 685-691","DOI":"10.1093\/eurheartj\/ehl197"},{"key":"10.1160\/TH12-08-0578-47","doi-asserted-by":"crossref","unstructured":"Zannad F, et al.; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011; 364: 11-21","DOI":"10.1056\/NEJMoa1009492"},{"key":"10.1160\/TH12-08-0578-48","doi-asserted-by":"crossref","unstructured":"Kjekshus J, et al.; CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007; 357: 2248-2261","DOI":"10.1056\/NEJMoa0706201"},{"key":"10.1160\/TH12-08-0578-49","doi-asserted-by":"crossref","unstructured":"Massie BM, et al.; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359: 2456-2467","DOI":"10.1056\/NEJMoa0805450"},{"key":"10.1160\/TH12-08-0578-50","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000144474.65922.AA"},{"key":"10.1160\/TH12-08-0578-51","first-page":"1424","volume":"33","author":"Stevenson","year":"1993","journal-title":"Circulation"},{"key":"10.1160\/TH12-08-0578-52","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(50)90129-3"},{"key":"10.1160\/TH12-08-0578-53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195002092420603"},{"key":"10.1160\/TH12-08-0578-54","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-37-5-867","volume":"37","author":"Griffith","year":"1952","journal-title":"Ann Int Med"},{"key":"10.1160\/TH12-08-0578-55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.03.010"},{"key":"10.1160\/TH12-08-0578-56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2006.02.012"},{"key":"10.1160\/TH12-08-0578-57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.801753"},{"key":"10.1160\/TH12-08-0578-58","doi-asserted-by":"crossref","unstructured":"Homma S, et al.; WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366: 1859-1869","DOI":"10.1056\/NEJMoa1202299"},{"key":"10.1160\/TH12-08-0578-59","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn309"},{"key":"10.1160\/TH12-08-0578-60","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs033"},{"key":"10.1160\/TH12-08-0578-61","doi-asserted-by":"crossref","unstructured":"Hunt SA, et al.; American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-e90","DOI":"10.1016\/j.jacc.2008.11.013"},{"key":"10.1160\/TH12-08-0578-62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2010.04.004"},{"key":"10.1160\/TH12-08-0578-63","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.106.478685"},{"key":"10.1160\/TH12-08-0578-64","doi-asserted-by":"crossref","unstructured":"Ip J, et al.; IMPACT Investigators. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Am Heart J 2009; 158: 364-370.e1","DOI":"10.1016\/j.ahj.2009.07.002"},{"key":"10.1160\/TH12-08-0578-65","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-10-0690"},{"key":"10.1160\/TH12-08-0578-66","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"10.1160\/TH12-08-0578-67","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-07-0491"},{"key":"10.1160\/TH12-08-0578-68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61233-1"},{"key":"10.1160\/TH12-08-0578-69","doi-asserted-by":"crossref","unstructured":"Warkentin AE, et al. Bleeding Risk in Randomized Controlled Trials Comparing Warfarin and Aspirin: a Systematic Review and Meta-Analysis. J Thromb Haemost 2012; epub ahead of print","DOI":"10.1111\/j.1538-7836.2012.04635.x"},{"key":"10.1160\/TH12-08-0578-70","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.038687"},{"key":"10.1160\/TH12-08-0578-71","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.6.734"},{"key":"10.1160\/TH12-08-0578-72","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000044389.51236.91"},{"key":"10.1160\/TH12-08-0578-73","first-page":"63","volume":"8","author":"Bleiweis","year":"1994","journal-title":"Am J Card Imag"},{"key":"10.1160\/TH12-08-0578-74","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192628"},{"key":"10.1160\/TH12-08-0578-75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2003.09.009"},{"key":"10.1160\/TH12-08-0578-76","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfp142"},{"key":"10.1160\/TH12-08-0578-77","doi-asserted-by":"publisher","DOI":"10.1177\/0898264307304448"},{"key":"10.1160\/TH12-08-0578-78","doi-asserted-by":"publisher","DOI":"10.1016\/S1543-5946(04)90006-2"},{"key":"10.1160\/TH12-08-0578-79","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-3991(02)00197-0"},{"key":"10.1160\/TH12-08-0578-80","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2004.06.007"},{"key":"10.1160\/TH12-08-0578-81","doi-asserted-by":"crossref","unstructured":"Lip GYH, Chung I. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Cochrane Database Syst Rev 2000, 2: CD003333","DOI":"10.1002\/14651858.CD003333"},{"key":"10.1160\/TH12-08-0578-82","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"10.1160\/TH12-08-0578-83","doi-asserted-by":"crossref","unstructured":"Camm AJ, et al. 2012 focused update of the ESC Guidelines forthe Management of Atrial Fibrillation. An update of the 2010 ESC Guidelines for the Management of Atrial Fibrillation. Eur Heart J 2012; epub ahead of print,","DOI":"10.1007\/978-1-908517-31-9_17"},{"key":"10.1160\/TH12-08-0578-84","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2306"},{"key":"10.1160\/TH12-08-0578-85","first-page":"CD003336","volume":"6","author":"Lip","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1160\/TH12-08-0578-86","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-08-0580"},{"key":"10.1160\/TH12-08-0578-87","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-04-0262"},{"key":"10.1160\/TH12-08-0578-88","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-08-0602"},{"key":"10.1160\/TH12-08-0578-89","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61751-7"},{"key":"10.1160\/TH12-08-0578-90","doi-asserted-by":"crossref","unstructured":"Costanzo MR, et al.; International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29: 914-956","DOI":"10.1016\/j.healun.2010.05.034"},{"key":"10.1160\/TH12-08-0578-91","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000129414.95137.CD"},{"key":"10.1160\/TH12-08-0578-92","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-05-0327"},{"key":"10.1160\/TH12-08-0578-93","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.958108"},{"key":"10.1160\/TH12-08-0578-94","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-137-8-200210150-00006","volume":"137","author":"Gottdiener","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1160\/TH12-08-0578-95","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"10.1160\/TH12-08-0578-96","unstructured":"Pullicino PM, et al. Identifying a high stroke risk subgroup in individuals with heart failure. J Stroke Cerebrovasc Dis 2012; in press"},{"key":"10.1160\/TH12-08-0578-97","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs005"},{"key":"10.1160\/TH12-08-0578-98","doi-asserted-by":"crossref","unstructured":"Connolly SJ, et al.; AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364: 806-817","DOI":"10.1056\/NEJMoa1007432"},{"key":"10.1160\/TH12-08-0578-99","unstructured":"McMurray JJV. Apixaban versus warfarin in patients with atrial fibrillation: outcomes according to left ventricular systolic function and heart failure status in ARISTOTLE. Heart Failure Congress 2012; May 20, 2012; Belgrade, Serbia. Presentation 160"},{"key":"10.1160\/TH12-08-0578-100","doi-asserted-by":"crossref","unstructured":"Patel MR, et al.; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891","DOI":"10.1056\/NEJMoa1009638"},{"key":"10.1160\/TH12-08-0578-101","doi-asserted-by":"crossref","unstructured":"Connolly SJ, et al.; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151","DOI":"10.1056\/NEJMoa0905561"},{"key":"10.1160\/TH12-08-0578-102","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-10-0642"},{"key":"10.1160\/TH12-08-0578-103","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-07-0463"},{"key":"10.1160\/TH12-08-0578-104","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-11-0758"},{"key":"10.1160\/TH12-08-0578-105","doi-asserted-by":"crossref","unstructured":"Pengo V, et al.; Italian Federation of Thrombosis Centers. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA). Thromb Haemost 2011; 106: 868-876","DOI":"10.1160\/TH11-05-0358"},{"key":"10.1160\/TH12-08-0578-106","doi-asserted-by":"crossref","unstructured":"Homma S. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF) trial. Heart Failure Society of America 2012 Scientific Meeting; September 10, 2012. Seattle, WA, USA","DOI":"10.1016\/j.cardfail.2012.10.002"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH12-08-0578.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T23:00:44Z","timestamp":1562281244000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH12-08-0578"}},"subtitle":["An Executive Summary of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis"],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":106,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,29]]},"published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1160\/th12-08-0578","relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}